Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PBOX-6 shows potential for bypassing apoptotic suppressor Bcr-Abl in CML

Jan. 30, 2001

Geron regains rights to telomerase inhibitors from Pharmacia; forms new division

Jan. 30, 2001

Somatostatin and neuromedin B receptor agonists and their use

Jan. 29, 2001

New isocoumarins with antiangiogenic activity claimed by Korean scientists

Jan. 29, 2001

Selective aromatase inhibitors show promise in early or preventive breast cancer treatment

Jan. 29, 2001

Apoptosis inducers emerge from R&D at Nippon Kayaku

Jan. 26, 2001

Neurim team discovers new melatonin-related compounds with unique profile

Jan. 26, 2001

New Isis antisense compounds modulate hnRNP A1 expression

Jan. 26, 2001

NDA for abarelix depot officially filed by FDA; drug assigned priority review status

Jan. 26, 2001

Introgen awarded SBIR grant to study INGN-241 as lung cancer treatment

Jan. 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...